Empagliflozin improves BP, A1C in diabetes, hypertension

06/25/2014 | Healio (free registration)

Empagliflozin fared better than placebo in improving blood pressure and A1C in hypertensive type 2 diabetes patients, researchers reported at the joint meeting of the International Society of Endocrinology and the Endocrine Society. Data also showed fewer patients in the intervention arm reported adverse events compared with the placebo cohort.

View Full Article in:

Healio (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA